Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L15 pseudogene 6 (RPL15P6) is a processed non-coding pseudogene located in the human genome. Pseudogenes such as RPL15P6 are DNA sequences derived from functional genes (in this case, ribosomal protein L15, encoded by RPL15), but they have lost protein-coding capability due to mutations, deletions, or lack of regulatory elements. RPL15P6 has no confirmed biological function, regulatory role, or disease association, and is not considered a drug target. Pseudogenes are commonly found throughout the genome and may occasionally be studied for evolutionary or genomic instability contexts, but do not serve as classical therapeutic targets
None known
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L15 pseudogene 6 (RPL15P6).